fidexaban and rivaroxaban

fidexaban has been researched along with rivaroxaban in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheney, DL; Knabb, RM; Pinto, DJ; Smallheer, JM; Wexler, RR	1
Doggrell, SA	1

Reviews

2 review(s) available for fidexaban and rivaroxaban

Article	Year
Factor Xa inhibitors: next-generation antithrombotic agents. Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17 Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis	2010
Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease? Reviews on recent clinical trials, 2011, Volume: 6, Issue:2 Topics: Amidines; Coronary Artery Disease; Cyclic N-Oxides; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Naphthalenes; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes	2011

Article

Year

Factor Xa inhibitors: next-generation antithrombotic agents.

Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17

Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis

2010

Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?

Reviews on recent clinical trials, 2011, Volume: 6, Issue:2

Topics: Amidines; Coronary Artery Disease; Cyclic N-Oxides; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Naphthalenes; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes

2011